Exchange: OTC·Updated 01:43 PM EDT

NAVB Navidea Biopharmaceuticals Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsMar 21
Mkt Cap$10,008.00
Vol450.00

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Columbus, OH.
60

Bullish Sentiment

How do you feel about NAVB?

Advertisement|Remove ads.